Disease |
Gene1 |
Animal model2 |
SC exhaustion3 |
Inherited musculear dystrophies |
|
|
|
Becker Muscular dystrophy |
Dystrophin (Xp21) |
MDX mouse [16], mild phenotype |
Indirect: Functional change: extensive activation; change in environment [35] |
Congenital Muscular disorders |
Laminin A2/Merosin (6q22-6q23)e.g. |
Laminin A2-deficient mouse [17] |
|
|
Integrin A7 (12.q13.2) |
Integrin A7-deficient mouse [18] |
Indirect? Changes in environment (loss of integrin A7) [36] |
|
Fukutin (9q31-q33) |
Fukutin chimeric mouse [19] |
|
|
SEPN1 (1p36) |
SEPN1-deficient mouse [20] |
Direct: increased proliferation SCs [37] |
Duchenne Muscular Dystrophy |
Dystrophin (Xp21) |
MDX mouse [16]; GRMD dogs [21] |
Indirect: Functional change: extensive activation; change in environment [35] |
Emery-Dreifuss |
Emerin (Xq28) |
Emerin-deficient mouse [22] |
Direct: Premature differentiation/cell cycle exit [38] |
|
Lamin A/C (1q11-q21) |
Lamin a-deficient mouse [23] |
|
Facioscapulohumeral muscular dystrophy |
FSHMD1A, D4Z4 contraction (95%; 4q35) |
FRG-1 transgenic mouse [24] |
Direct and indirect: Increased apoptosis of myoblast/inhibition of differentiation [39,40] |
Limb-Girdle Muscular Dystrophy |
Dysferlin (2p13.2) |
Dysferlin-deficient mouse [25] |
Indirect: Inhibition of myoblast fusion [41] |
|
e.g. Alpha-sarcoglycan (17q12- 21.33) |
BIO 14.6 hamster [26] |
|
|
POMT1 (9q34.1) and POMT2 (14q24.3) |
POMT1-deficiency in mouse is embryonic letal [27] |
Indirect; apoptosis in droshophila myoblasts [42] |
Myotonic Dystrophy |
DMPK (DM1; 19q13.2-q13.3) |
DMPK-deficient mice [28] |
Indirect: myoblast dysfunction was reported [43] |
|
ZNF9 (DM2; 3q21) |
ZNF9+/- mouse [29] |
|
Oculopharyngeal muscular dystrophy |
PABPN1 (14q) |
Transgenic mouse expressing mutated PABPN1 [30] |
Direct and indirect: defects in myoblast differentiation and proliferation [44] |
Metabolic Myopathies |
|
|
|
Late-onset Pompe Diseaseacid |
alpha-glucosidase (17q25.2-q25.3) |
GAAKO mouse [31,32] |
Unknown: Increased SC activation reported [45] |
Other |
|
|
|
Stress Urinary incontinence4 |
Ageing |
Models reviewed by [33] |
Indirect: Age-related loss of replicative potential, apoptosis) [46] |
Chronic Obstructive Pulmonary Disease (COPD) |
alpha-1 antitrypsin (14q32.1) implicated |
Klotho knockout [34] |
Indirect: replicative senescence/reduction minimal telomere length [47] |